MXPA03001320A - Agentes no peptidicos de la gnrh, composiciones farmaceuticas y procedimientos para su uso. - Google Patents
Agentes no peptidicos de la gnrh, composiciones farmaceuticas y procedimientos para su uso.Info
- Publication number
- MXPA03001320A MXPA03001320A MXPA03001320A MXPA03001320A MXPA03001320A MX PA03001320 A MXPA03001320 A MX PA03001320A MX PA03001320 A MXPA03001320 A MX PA03001320A MX PA03001320 A MXPA03001320 A MX PA03001320A MX PA03001320 A MXPA03001320 A MX PA03001320A
- Authority
- MX
- Mexico
- Prior art keywords
- methods
- pharmaceutical compositions
- agents
- peptide gnrh
- gnrh agents
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/16—Masculine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
- A61P5/04—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin for decreasing, blocking or antagonising the activity of the hypothalamic hormones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Biomedical Technology (AREA)
- Diabetes (AREA)
- Pregnancy & Childbirth (AREA)
- Urology & Nephrology (AREA)
- Physical Education & Sports Medicine (AREA)
- Anesthesiology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Gynecology & Obstetrics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US35656102P | 2002-02-12 | 2002-02-12 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MXPA03001320A true MXPA03001320A (es) | 2003-08-21 |
Family
ID=27613554
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MXPA03001320A MXPA03001320A (es) | 2002-02-12 | 2003-02-11 | Agentes no peptidicos de la gnrh, composiciones farmaceuticas y procedimientos para su uso. |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US6833372B2 (es) |
| EP (1) | EP1334972B1 (es) |
| JP (1) | JP2004002309A (es) |
| AT (1) | ATE323699T1 (es) |
| AU (1) | AU2003202115A1 (es) |
| BR (1) | BR0300599A (es) |
| CA (1) | CA2418712A1 (es) |
| DE (1) | DE60304609D1 (es) |
| MX (1) | MXPA03001320A (es) |
| WO (1) | WO2003068769A1 (es) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7205307B2 (en) * | 2002-02-14 | 2007-04-17 | Icagen, Inc. | Pyrimidines as novel openers of potassium ion channels |
| PL212089B1 (pl) * | 2002-03-13 | 2012-08-31 | Janssen Pharmaceutica Nv | Związki heterocykliczne jako inhibitory deacetylazy histonowej, kompozycja farmaceutyczna je zawierająca, ich zastosowanie, sposób wytwarzania, sposób wykrywania lub identyfikacji HDAC oraz kompozycja |
| US20040033986A1 (en) | 2002-05-17 | 2004-02-19 | Protopopova Marina Nikolaevna | Anti tubercular drug: compositions and methods |
| US7652039B2 (en) | 2002-05-17 | 2010-01-26 | Sequella, Inc. | Methods of use and compositions for the diagnosis and treatment of infectious disease |
| US7456222B2 (en) | 2002-05-17 | 2008-11-25 | Sequella, Inc. | Anti tubercular drug: compositions and methods |
| MXPA04012566A (es) * | 2002-06-13 | 2005-04-19 | Pfizer | Agentes no peptidicos reguladores de la gnrh, composiciones farmaceuticas y procedimientos para su uso. |
| DE60307313T2 (de) * | 2002-11-20 | 2006-12-14 | Paradigm Therapeutics Ltd. | Heterozyklische siliziumverbindungen und deren verwendung zur behandlung von krankheiten oder zuständen, die mit gnrh (gonadotropinfreisetzendem hormon) assoziiert sind |
| ATE532772T1 (de) | 2003-07-30 | 2011-11-15 | Xenon Pharmaceuticals Inc | Piperazinderivate und deren verwendung als therapeutische mittel |
| WO2005034857A2 (en) | 2003-09-05 | 2005-04-21 | Sequella, Inc. | Methods and compositions comprising diamines as new anti-tubercular therapeutics |
| KR100751314B1 (ko) * | 2003-10-14 | 2007-08-22 | 삼성에스디아이 주식회사 | 어드레싱 전력을 최소화한 방전 디스플레이 장치 및 그구동 방법 |
| US20050089559A1 (en) | 2003-10-23 | 2005-04-28 | Istvan Szelenyi | Combinations of potassium channel openers and sodium channel inhibitors or sodium channel-influencing active compounds for treating pains |
| EP1896465A1 (en) * | 2005-06-28 | 2008-03-12 | Takeda Cambridge Limited | Heterocyclic non-peptide gnrh antagonists |
| US7683058B2 (en) | 2005-09-09 | 2010-03-23 | H. Lundbeck A/S | Substituted pyrimidine derivatives |
| KR20080043314A (ko) * | 2005-09-09 | 2008-05-16 | 하. 룬트벡 아크티에 셀스카브 | 피리미딘 유도체 및 ｋｃｎｑ 포타슘 채널 개방제로서의그의 용도 |
| US7960436B2 (en) | 2006-06-05 | 2011-06-14 | Valeant Pharmaceuticals International | Substituted arylamino-1,2,3,4-tetrahydro naphthalenes and-2,3-dihydro-1H-indenes as potassium channel modulators |
| ES2420960T3 (es) | 2006-08-23 | 2013-08-28 | Valeant Pharmaceuticals International | Derivados de 4-(N-azacicloalquil)anilidas como moduladores de los canales de potasio |
| US8993593B2 (en) | 2006-08-23 | 2015-03-31 | Valeant Pharmaceuticals International | N-(4-(6-fluoro-3,4-dihydroisoquinolin-2(1H)-yl)-2,6-dimethylphenyl)-3,3-dimethylbutanamide as potassium channel modulators |
| US8722929B2 (en) | 2006-10-10 | 2014-05-13 | Valeant Pharmaceuticals International | N-[2-amino-4-(phenylmethoxy)phenyl] amides and related compounds as potassium channel modulators |
| ES2375417T3 (es) | 2006-11-28 | 2012-02-29 | Valeant Pharmaceuticals International | Análogos 1,4-diamino bicíclicos de retigabina como moduladores de los canales de potasio. |
| US8367684B2 (en) | 2007-06-13 | 2013-02-05 | Valeant Pharmaceuticals International | Derivatives of 4-(N-azacycloalkyl) anilides as potassium channel modulators |
| US8563566B2 (en) | 2007-08-01 | 2013-10-22 | Valeant Pharmaceuticals International | Naphthyridine derivatives as potassium channel modulators |
| US7786146B2 (en) | 2007-08-13 | 2010-08-31 | Valeant Pharmaceuticals International | Derivatives of 5-amino-4,6-disubstituted indole and 5-amino-4,6-disubstituted indoline as potassium channel modulators |
| TW201008933A (en) * | 2008-08-29 | 2010-03-01 | Hutchison Medipharma Entpr Ltd | Pyrimidine compounds |
| ES2649995T3 (es) | 2011-07-18 | 2018-01-16 | Merck Patent Gmbh | Benzamidas |
| EP2986603A1 (en) * | 2013-04-19 | 2016-02-24 | Oslo Universitetssykehus HF | Radiolabeled gnrh antagonists as pet imaging agents |
| CN108164397B (zh) * | 2018-01-18 | 2020-11-13 | 暨南大学 | 一类邻苯二酚衍生物及其制备方法 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1993003058A2 (en) | 1991-07-01 | 1993-02-18 | University Technologies International Inc. | NON-DESENSITIZING ANALOGS OF GnRH AND OTHER BIOLOGICALLY ACTIVE LIGANDS |
| US6136781A (en) | 1995-04-28 | 2000-10-24 | Takeda Chemical Industries, Ltd. | LH-RH receptor antagonists |
| AU5844896A (en) | 1995-06-01 | 1996-12-18 | Takeda Chemical Industries Ltd. | Tricyclic diazepines useful as gnrh receptor antagonists |
| HUP9903671A3 (en) | 1995-12-14 | 2001-11-28 | Merck & Co Inc | Antagonists of gonadotropin releasing hormone, pharmaceutical compositions and process for producing them |
| CA2240115A1 (en) | 1995-12-14 | 1997-06-19 | Wallace T. Ashton | Antagonists of gonadotropin releasing hormone |
| KR19990072124A (ko) | 1995-12-14 | 1999-09-27 | 애쉬톤 왈레이스 티 | 고나도트로핀 방출 호르몬의 길항제 |
| WO1997021707A1 (en) | 1995-12-14 | 1997-06-19 | Merck & Co., Inc. | Antagonists of gonadotropin releasing hormone |
| US6200957B1 (en) | 1995-12-14 | 2001-03-13 | Merck & Co., Inc. | Antagonists of gonadotropin releasing hormone |
| US6218426B1 (en) | 1998-03-05 | 2001-04-17 | Agouron Pharmaceuticals, Inc. | Non-peptide GnRH agents |
| US5972898A (en) | 1998-03-27 | 1999-10-26 | Abbott Laboratories | 3',3-N-bis-substituted macrolide LHRH antagonists |
| TR200100631T2 (tr) * | 1998-08-20 | 2002-08-21 | Agouron Pharmaceuticals,Inc. | Peptit-olmayan GnRH maddeleri |
| US6020521A (en) | 1998-08-26 | 2000-02-01 | Abbott Laboratories | Macrolide LHRH antagonists |
| US6387885B1 (en) | 1998-08-26 | 2002-05-14 | Abbott Laboratories | 3′,3′-N-bis-desmethyl-3′-N-cycloalkyl erythromycin derivatives as LHRH antagonists |
| US5981521A (en) | 1998-11-13 | 1999-11-09 | Abbott Laboratories | Tetrahydroisoquinoline derivatives as LHRH antagonists |
| FR2793594B1 (fr) | 1999-05-11 | 2001-12-07 | Axon Cable Sa | Cable passe-bas |
| KR20020045609A (ko) | 1999-10-15 | 2002-06-19 | 추후기재 | 고나도트로핀-분비 호르몬 수용체 길항제 및 이와 관련된방법 |
-
2003
- 2003-01-29 WO PCT/IB2003/000316 patent/WO2003068769A1/en not_active Application Discontinuation
- 2003-01-29 AU AU2003202115A patent/AU2003202115A1/en not_active Abandoned
- 2003-01-30 AT AT03250563T patent/ATE323699T1/de not_active IP Right Cessation
- 2003-01-30 EP EP03250563A patent/EP1334972B1/en not_active Expired - Lifetime
- 2003-01-30 DE DE60304609T patent/DE60304609D1/de not_active Expired - Lifetime
- 2003-02-10 CA CA002418712A patent/CA2418712A1/en not_active Abandoned
- 2003-02-11 US US10/364,193 patent/US6833372B2/en not_active Expired - Fee Related
- 2003-02-11 MX MXPA03001320A patent/MXPA03001320A/es unknown
- 2003-02-12 JP JP2003034331A patent/JP2004002309A/ja active Pending
- 2003-02-12 BR BR0300599-2A patent/BR0300599A/pt not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CA2418712A1 (en) | 2003-08-12 |
| AU2003202115A1 (en) | 2003-09-04 |
| DE60304609D1 (de) | 2006-05-24 |
| ATE323699T1 (de) | 2006-05-15 |
| US6833372B2 (en) | 2004-12-21 |
| EP1334972A1 (en) | 2003-08-13 |
| BR0300599A (pt) | 2005-03-29 |
| US20040053951A1 (en) | 2004-03-18 |
| EP1334972B1 (en) | 2006-04-19 |
| JP2004002309A (ja) | 2004-01-08 |
| WO2003068769A1 (en) | 2003-08-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MXPA03001320A (es) | Agentes no peptidicos de la gnrh, composiciones farmaceuticas y procedimientos para su uso. | |
| AP2001002053A0 (en) | No-peptide GnRH agents, methods and intermediates for their preparation. | |
| LV12631A (en) | Non-peptide gnrh agents | |
| DE602004026053D1 (es) | ||
| JO2355B1 (en) | Hereditary calcitonin polypeptide receptor antagonists | |
| MX9804850A (es) | Antagonistas de hormona liberadora de gonadotropina. | |
| ATE334674T1 (de) | Verwendung von oestrogen-agonisten oder - antagonisten zur behandlung von sexuellen funktionsstörungen | |
| EP1364659A4 (en) | REMEDIES FOR URINARY DISEASES CONTAINING LPA RECEPTOR REGULATING AGENTS | |
| IL180603A (en) | 3,4-Dihydro-1 H- Naphthalanones which are glucocorticoid receptor modulators | |
| EP1796678A4 (en) | CARBOXAMIDE SPIROLACTAM CGRP RECEPTOR ANTAGONISTS | |
| EP1606286A4 (en) | BENZODIAZEPINE SPIROHYDANTOINES AS CGRP RECEPTOR ANTAGONISTS | |
| WO2005000807A3 (en) | Benzodiazepine cgrp receptor antagonists | |
| WO2002098363A3 (en) | NON-PEPTIDE GnRH AGENTS, PHARMACEUTICAL COMPOSITIONS AND METHODS FOR THEIR USES, AND PROCESSES FOR PREPARING THEM | |
| ATE311765T1 (de) | Mischung enthaltend procyanidine zur verminderung des appetits bei säugetieren | |
| AU2003255820A1 (en) | Derivatives of 3-hydroxy-4-(cyclyl-alkylaminoalkyl)-5-phenyl-1h-pyrazole as antagonists of the gonadotropin releasing hormone (gnrh) for use in the treatment of sex hormone related conditions, such as prostatic of uterine cancer | |
| AR036337A1 (es) | Composicion farmaceutica inyectable que comprende un peptido antagonista de gnrh, un conjunto farmaceutico, metodo de tratamiento y uso de un peptido antagonista de gnrh. | |
| MA35867B1 (fr) | Dérivés de la spiroindoline comme antagonistes du récepteur de l'hormone libérant la gonatrophine (gnrh) | |
| AU2003267551A1 (en) | Thieno-pyrrole compounds as antagonists of gonadotropin releasing hormone | |
| ATE277926T1 (de) | Trizyclische vasopressin agoniste | |
| GB2407504A (en) | Optimal volume of intra-vaginal semisolid dosage forms for treating vaginal infections | |
| HUP0102805A2 (hu) | Tienopiridin-származékok, előállításuk és alkalmazásuk | |
| CN116096371A8 (zh) | 含有饱和含氧杂环基的嘧啶二酮类化合物及其用途 | |
| PE20010578A1 (es) | Mesoprogestinas (modulares de receptores de progesterona) para el tratamiento y la prevencion de trastornos ginecologicos benignos hormona-dependientes | |
| DE60122575D1 (de) | 7-HETEROCYCLYL-SUBSTITUIERTE CHINOLIN- UND THIENOi2,3-BöPYRIDIN-DERIVATE ALS ANTAGONISTEN DES GONADOTROPIN-FREISETZENDEN HORMONS | |
| WO2000066620A3 (en) | Morphogen-induced enhancement of fertility |